Morningstar will cease full analyst coverage of Harding Loevner Global Equity (which includes a US mutual fund, a US separately managed account, and a European cross-border mutual fund) on or around July 26, 2024, so our analysts can spend more time researching other strategies. In the future, this strategy will receive an algorithmically assigned Morningstar Medalist Rating. Users should form their own views on this strategy or obtain financial advice.
Harding Loevner Global Equity Advisor HLMGX
- NAV / 1-Day Return 42.34 / +1.29 %
- Total Assets 730.8 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.130%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Global Large-Stock Growth
- Investment Style Large Growth
- Min. Initial Investment 5,000
- Status Open
- TTM Yield 0.06%
- Turnover 28%
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:12 PM GMT+0
Morningstar’s Analysis HLMGX
Will HLMGX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 37.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Microsoft Corp | 4.85 | 47.3 Mil | Technology |
Meta Platforms Inc Class A | 4.71 | 45.9 Mil | Communication Services |
Alphabet Inc Class A | 4.63 | 45.1 Mil | Communication Services |
Amazon.com Inc | 4.50 | 43.8 Mil | Consumer Cyclical |
Schneider Electric SE | 4.43 | 43.1 Mil | Industrials |
Vertex Pharmaceuticals Inc | 4.34 | 42.3 Mil | Healthcare |
Netflix Inc | 2.90 | 28.3 Mil | Communication Services |
Northern Institutional Treasury Premier | 2.85 | 27.7 Mil | Cash and Equivalents |
Thermo Fisher Scientific Inc | 2.53 | 24.6 Mil | Healthcare |
Alcon Inc | 2.33 | 22.7 Mil | Healthcare |